Biocracked
**Approach:** Conceptual metaphor. **Palette:** D, bold color field.

A single AA-style battery stands upright on a saturated tomato-red matte backdrop. Its casing is cleanly cut away so the cells inside show as a real cross-section. A thin, steady bead of electric green gel or liquid sits at a constant level inside the cell. Beside it, a worn analog pressure gauge on a rubber tube, its needle pushed into the upper range, stands for hypertension. A white coiled stethoscope tubing curls loosely across the foreground.

Shot at a slightly low, eye-level three-quarter angle with a 50mm lens and shallow depth of field. Lighting is hard, crisp studio key light from the upper left. It casts sharp, warm-neutral shadows on the red surface and bright specular highlights on the metal.

The mood is skeptical and analytical: stable, not draining, with the real warning sign sitting next to it.
Longevity

NAD a Jini Ba Ya Raguwa da Shekaru; Yana Bin Cutar Zuciya

Dr. Synapse · · 5 min read

Shekaru da dama, talla da ke ƙarfafa NAD+ ta ginu kan hujja ɗaya mai sauƙi: NAD na raguwa da tsufa, don haka ya kamata a cike gurbin da ake rasa. Sai wani sabon takarda da aka wallafa a Nature Metabolism ya kalubalanci wannan ra'ayi, aƙalla idan an auna NAD a jinin ɗan adam. A cikin manya masu lafiya, matakin NAD a jini gaba ɗaya bai ragu da shekarun su ba. Abin da aka samu shi ne cewa matakin ƙasa na NAD yana alaƙa da cutar zuciya da hauhawar jini.

Menene Binciken Ya Gano a Gaskiya

Binciken, da Romenskaja‑Avgul, Stakelytė, da Laurynėnas suka jagoranta, ya auna NAD a jini gaba ɗaya a cikin manya 1,068 (jimillar auna 1,340). Manufar ita ce ƙara fahimtar ko matakin NAD a jini yana canzawa da tsufa ko da cuta.

Sakamakon ya kasu biyu:

  • A cikin mutanen da ke da lafiya, NAD ba ya raguwa da shekaru. Matakin ya tsaya daidai a maza, kuma ya ƙaru a mata.
  • A cikin mutanen da ke da cututtuka masu tsanani, NAD ya kasance ƙasa. Ragewar ta danganci musamman cutar zuciya da hauhawar jini.

Marubutan sun taƙaita wannan da cewa NAD a jini gaba ɗaya yana bin alamar cutar zuciya maimakon shekarun da aka haifa.

Dalilin Da Ya Sa Wannan Ke Sabawa da Labarin Da Aka Yawaita

Ra'ayin cewa NAD yana raguwa a hankali tun daga balaga yana ɗaya daga cikin shahararrun maganganu a duniyar tsawaita rayuwa. An samo shi ne daga bincike a dabbobi da ƙananan bayanai na mutane, kuma ya haifar da kasuwa mai faɗi ga kayan ƙara NAD kamar NR, NMN, da magungunan IV NAD+.

Wannan bincike ba ya nuni da cewa NAD a ƙwayoyin ba ya raguwa kwata-kwata; ya auna kawai a cikin jini gaba ɗaya, wato wani ɓangare ne na jiki, ba tsoka, kwakwalwa, hanta ko kitse ba. Amma girman bayanan yana da muhimmanci a wannan fanni, kuma ya saba da tunanin cewa karatun NAD a jini yana ƙasa ne kawai saboda tsufa.

A aikace, wannan na nufin cewa shekaru kaɗai ba su isa su zama dalilin da ya sa NAD a jinin ka ya ƙasa ba. Idan kana da lafiya, hujjar "kana rasa NAD yayin da kake tsufa" ba lallai ta shafi matakin NAD a jini ba.

Bambancin Jinsi Da Ya Kamata A Lura Da Shi

Bambancin jinsi ya fito fili a cikin sakamakon. Maza masu lafiya sun tsaya daidai, yayin da mata masu lafiya suka nuna ƙaruwa da tsufa. Samfurin da ke ɗaukar sauƙin raguwa na layi ba zai iya hango wannan bambanci ba. Takaitaccen bayani bai ba da dalili ba, don haka duk wani tunani kan canjin hormone, ƙamshin jini ko adadin ƙwayoyin jini ja su ne zato kawai. Wannan yana nuna cewa "NAD da shekaru" ba tsari mai layi ba ne, kuma haɗa maza da mata a bincike guda na iya ɓoye muhimman bambance-bambance.

Cutar Zuciya da Hauhawar Jini: Alamar Da Ta Fi Karfi

Alamar da ta fi ƙarfi a cikin bayanan ita ce alaka tsakanin NAD a jini gaba ɗaya da ke ƙasa da cutar zuciya da hauhawar jini. Wannan ya dace da sha'awar kimiyya game da tsarin NAD da lafiyar jijiyoyi, tunda NAD yana da mahimmanci wajen sarrafa makamashi na sel da daidaiton redox, kuma zuciya na buƙatar ƙarfi sosai.

Amma yadda alakar take yana da mahimmanci, kuma wannan bincike ba zai iya ƙayyade ko wane ne sanadi ba. NAD ƙasa na iya ƙara haifar da cuta; hanyoyin cuta, kumburi, magunguna ko salon rayuwa da ke da alaƙa da rashin lafiya na iya rage NAD. Ko wani abu na uku ne ke haifar da duka biyun. Marubutan sun bayyana wannan a sarari.

Gargaɗi Muhimmanci: Ba Shaida Ga Magani Ba

Marubutan sun bayyana a fili cewa ba a tsara wannan bincike don tantance dalili ba. Saboda haka bayanan ba su ba da hujja kai tsaye cewa ƙara NAD zai iya zama magani ga cutar zuciya ko hauhawar jini.

Wannan sau da yawa ana wucewa a fannin da ke ƙaura da sauri daga alaka zuwa samfur. Samuwar biomarker ƙasa a cikin mutanen da ke da cuta ba yana nufin ƙara biomarker zai warkar da su ba. Yawancin biomarker da ke bin cuta suna zama sakamako ne, ba maɓalli ba. Kawai gwaje-gwajen shiga da magani za su nuna ko dawowar NAD na canza sakamakon lafiya.

Abubuwan Da Masu Binciken Kai Na Kansa Zasu Iya Amfani Da Su

Ga mutanen da ke bibiyar alamomin su, binciken ya ba da shawarwari da dama kan yadda za a fahimci bayanan NAD:

  1. Kada ka ɗauka cewa shekaru na nufin NAD ƙasa. Idan kai da lafiya, raguwa a NAD na jini ba dole ba ne saboda ka tsufa.
  2. Ka ɗauki karatun ƙasa a matsayin alamar lafiya, ba hukuncin shekaru ba. NAD a jini gaba ɗanya ƙasa na iya zama alamar matsalolin zuciya, hawan jini, kitse da sauransu.
  3. Mahalli yafi ƙima fiye da lamba guda. Jinsi, yanayin lafiya da hanyar auna duk suna tasiri kan fassarar sakamakon. Wannan binciken ya yi amfani da jini gaba ɗaya, kuma sakamakon na iya bambanta da na sauran nau'ikan samfuran ko matakan ƙwayoyin.
  4. Kasance mai shakku ga dabarun ƙara NAD da aka gina kan shekaru kawai. "Ni shekara 50, don haka ina bukatar NAD precursors" ba shi da goyon baya daga waɗannan bayanan.
  5. Kada ka yi maganin cutar zuciya da hauhawar jini da kayayyakin NAD da kanka. Marubutan sun ce bayanan ba su tallafa ƙara NAD a matsayin magani ga waɗannan cututtuka. Kula da likita na al'ada ga hawan jini da cutar zuciya shine hanyar da ke da hujja.
  6. Ka yi la'akari da bibiyar lokaci‑lokaci. Binciken ya haɗa da maimaita auna a wasu mahalarta, kuma bin diddigin kanka na iya ba da fahimta mafi kyau fiye da hoton lokaci guda.

Iyakoki Da Tambayoyi Da Ba a Amsa Ba

Har yanzu akwai tambayoyi da dama. NAD a jini gaba ɗaya yana ƙunshe da ƙwayoyin jini ja, don haka ba zai iya nuna NAD a ƙwayoyin da ake tunanin yana raguwa da tsufa ba. Takaitaccen bayani bai fayyace dandalin auna, tasirin magunguna ko bayanan demografik na mahalarta ba, don haka masu karatu su duba cikakken takarda kafin su yanke shawara mai ƙarfi. Kuma babban tambaya na ko NAD ƙasa a cutar zuciya sanadi ne, sakamakon cuta ko kuma al'amari mai zaman kansa har yanzu ba a magance ba.

Gabaɗaya

Wannan bincike yana sauya tambayar daga "shin NAD na raguwa da shekaru?" zuwa "menene NAD ƙasa a jini ke gaya mana game da lafiyar mu?" A cikin wannan bayanin, amsar ita ce yana iya magana fiye da shekarunka, yana nuni da yanayin zuciyarka. Wannan yana sanya NAD a jini gaba ɗaya alamar da zata iya zama mai ban sha'awa, amma ba a tabbatar da ita a matsayin hanyar magani ba tukuna. Ga duk wanda ke la'akari da ƙara NAD, sakon gaskiya shi ne hujjar raguwa da shekaru ta ƙare fiye da yadda aka saba, kuma hujjar magani da cuta har yanzu tana bukatar gwaje-gwajen klinik.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

DS

Written by

Dr. Synapse

Dr. Synapse writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: Macro science. Palette: D, bold color field.

An extreme close-up microscopy-style photograph of a single giant megakaryocyte cell, a large lumpy, lobed cell with a textured, slightly translucent surface, budding off dozens of tiny, smooth, disc-shaped platelets that drift away on fine stringy extensions. The cell and platelets are a warm pearly ivory with subtle coral-pink internal granules and a few small electric green (#00e676) fluorescent specks inside, suggesting recycling vesicles. The backdrop is a saturated, even tomato-red to deep orange color field with a soft gradient. Shot from slightly above at a three-quarter angle, with shallow depth of field so the nearest platelets are crisp and the distant ones melt into soft blur. Lighting is clean, diffuse and glowing from behind, giving gentle rim highlights. Mood: curious, precise, quietly cautionary. No text.
longevity

CoQ10 Ya Kwantar da ‘Tsoffin’ Platelet a Berayen Tsufa — Abin da Ya Kamata a Lura

BY NOVA CHEN ·

Sabuwar bincike a mujallar *Aging Cell* ya nuna CoQ10 na inganta aikin megakaryocytes masu tsufa a beraye, wanda ke rage haɗa‑haɗar platelet da ƙara kwanciyar su. Tasirin ya danganta da COPS3 da autophagy, amma binciken ya ƙunshi kawai beraye da ƙwayoyin a dakin gwaje‑gwaje; ba a sami bayanan mutane ba, kuma ba a tabbatar da cewa zai hana toshewar jini ba. Ga abin da ke nufi, abin da ba ya nufi, da kuma dalilin da ya sa masu amfani da magungunan rage jini su tattauna da likita kafin ɗaukar CoQ10.

Approach: Lab in action. Palette: B, warm.

Close, slightly high three-quarter angle on an isolated rat heart suspended in a Langendorff perfusion rig, the small dark-red heart held by its aorta on a glass cannula inside a warm-jacketed glass chamber. Clear perfusion fluid drips from the heart and beads on the glass. A gloved hand in the soft-focus foreground adjusts a stopcock. Amber, honey-colored light from a low side lamp rakes across the curved glass, producing copper highlights and warm brown shadows. Behind it, a blurred bench holds tubing and a small pressure transducer. A thin electric green (#00e676) indicator light glows on the instrument at the edge of the frame. Mood: quiet, focused, cautiously hopeful, with real laboratory texture and shallow depth of field. No text or labels.
longevity

Karin gina jiki biyu da suka fi tasiri wajen kare zukatan berayen tsofaffi – Abin da ya kamata ku sani

BY DR. SYNAPSE ·

Sabuwar bincike a kan beraye ta gano cewa haɗa NMN da melatonin na taimakawa zucukan berayen tsofaffi su warke daga raunin da ke kama da bugun zuciya, fiye da kowanne ɗayan maganin kadai. Zukatan da aka ba da maganin sun nuna ƙaruwa a gudun jinin coronary da dawowar matsa lamba, tare da raguwar matakan creatine kinase da alamu na ƙonewar jiki. Sai dai aikin an yi shi a kan zukatan da aka ware a waje, inda melatonin aka ƙara a cikin ruwan perfusion kuma NMN aka ba da ta allura, don haka ba a san yadda za su yi aiki a jikin mutum ba. Ga abin da masu binciken suka yi, sakamakon da suka samu, da dalilin da ya sa wannan mataki ke da mahimmanci.

Approach: conceptual metaphor. Palette: D, bold color field.

A tall glass of bright orange-gold liquid sits in the center of the frame, filled to the brim and overflowing down its sides, shot at a slight low angle. Beside it, a sealed, empty glass cylinder with a thin glass wall stays bone dry. A clear glass barrier stands between them, so the flow clearly never crosses. The backdrop is a saturated tomato-red seamless paper, with a glossy red surface reflecting both vessels. Hard, directional studio light from the upper left throws crisp, warm-neutral shadows and bright highlights along the glass rims and liquid droplets. One small electric green ring sits at the base of the empty cylinder as a subtle accent. Mood: tense, ironic, clean and editorial. Photorealistic, shallow depth of field, no text or labels.
supplements

CoQ10 na ƙaruwa a jini, amma ba ya kai ga mitochondria

BY NOVA CHEN ·

Wani sabon gwajin kan mutane ya duba tasirin karfafa ƙara CoQ10 a kan tsawon rai. A cikin manya 40 masu lafiya, masu shekaru a ƙasa da 80, shan 400 mg na CoQ10 a kowace rana na tsawon makonni 12 ya haɓaka matakin CoQ10 a jini, amma ba a samu wani canji a matakin CoQ10 a tsoka, a aikin mitochondria, ko a sarrafa sukari da VO₂max ba. Gwajin ya kasance ƙarami, gajere, kuma an yi shi ne a kan manya masu ƙarfi, yayin da babban marubuci ke bayar da shawara ga kamfanin Pharma Nord. Ga abin da sakamakon ke nuni da shi, abin da ba a iya faɗi ba, da kuma tambayoyin da har yanzu ke buƙatar amsa daga likita.

Approach: conceptual metaphor. Palette: D, bold color field.

A single cracked ceramic-white bone-shaped column, like a femur section, stands upright at the center of a saturated mustard-yellow seamless backdrop. A thin, clean hairline fracture runs through its middle. Beside it, a small golden-amber glass dropper bottle sits tipped, with one droplet suspended just above the bone and not touching it, which suggests extra vitamin D that makes no difference. The camera is at a low three-quarter angle with a shallow depth of field. Hard, directional studio light from the upper left casts a crisp, long shadow across the yellow floor. The porous bone texture is visible in fine detail. A tiny electric green (#00e676) droplet reflection glints on the glass. The mood is skeptical, cool-headed and editorial.
longevity

Vitamin D da Ake Shan Yawa don Ƙashi? Gwajin Shekaru 5 Ya Ce A'a

BY DR. SYNAPSE ·

Shin kana shan ƙarin vitamin D don ƙarfafa ƙasusuwa? Gwajin bazuwar da aka gudanar tsawon shekaru biyar a kan manyan Finnawa 2,495 ya nuna cewa ba ɗayan rukunin 1,600 IU/ran ko 3,200 IU/ran ba su rage haɗarin raunin ƙashi idan aka kwatanta da placebo. Abin mamaki, rukunin 1,600 IU ya fi samun rauni (HR 1.52), yayin da rukunin 3,200 IU ba shi da irin wannan tasiri, abin da ke nuni da yiwuwar sakamakon kuskure ne kawai. Masu halarta sun riga suna da matakin vitamin D na isasshe a farawa, don haka sakamakon ba ya shafar mutanen da ke da ƙarancin vitamin D. Ga abin da binciken ya gano, iyakokinsa, da abin da za a yi kafin yanke hukunci.

This page is available in